Visible Abdominal Distension (NCT06369753)
Tratamiento de la distensiΓ³n Abdominal Funcional
π©Ί Plain-English Summary (8th-Grade Level)
Background. Abdominal distention is produced by an abnormal somatic postural tone. The authors developed an original biofeedback technique. In a randomized, placebo-controlled trial the authors demonstrated the superiority of biofeedback over placebo for the treatment of abdominal distention. However, the technique is technically complex and unpractical. Aim. To prove the efficacy of a noninstrumental biofeedback technique, transmitted by a standard training program, for the treatment of abdominal distension in different centers. Selection criteria. Episodes of visible abdominal distension. Intervention. Patients will be randomized into biofeedback and placebo groups. Three sessions of either biofeedback or placebo intervention will be performed during the first 3 weeks of the intervention period. Biofeedback: Patients will be taught to control abdominal and thoracic muscular activity by providing instructions using an original video support. In each center one operator will receive a standard training on how to deliver the noninstrumental biofeedback treatment. Patients will be instructed to perform the same exercises before and after breakfast, lunch and dinner during the 4-week intervention period. Placebo: Sham measurements of abdominal and thoracic motion will be performed, and a pill of placebo containing 0.21 g glucose will be administered; patients will be instructed to take a pill of placebo before breakfast, lunch and dinner during the 4-week intervention period.
Who can join: Review the eligibility criteria below.
Location: G. Oppenheimer Center for Neurobiology of Stress and Resilience β Los Angeles, California
Age range: 18 Years to 80 Years
π§ͺ Interventions in This Study
- Biofeedback (BEHAVIORAL)
- Placebo (BEHAVIORAL)
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (7 Sites)
- G. Oppenheimer Center for Neurobiology of Stress and Resilience β Los Angeles, California
- McMaster University β Hamilton, Ontario
- Bordeaux University Hospital β Bordeaux,
- Santa Orsola Hospital β Bologna,
- Hospital Universitari Vall d'Hebron β Barcelona,
- Sahlgrenska Hospital, Gothenburg β Gothenburg,
- Manchester University β Manchester,
π Contact the Study Coordinator
Phone: 34 932746259
Email: azpiroz.fernando@gmail.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Irritable Bowel Syndrome
- Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS) β Boston, Massachusetts
- Pilot Study of the Physiological Effects of an Integrative Medicine Approach in Irritable Bowel Syndrome β Philadelphia, Pennsylvania
- A Well-Being Intervention for People With IBS β Madison, Wisconsin
- Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome β Camden, New Jersey
- Defining Objective Markers of Compliance for Dietary Therapies in IBS β Ann Arbor, Michigan
- Mucosal and Microbiota Changes During Acute Campylobacteriosis β Rochester, Minnesota
Explore by condition: All Irritable Bowel Syndrome clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.